These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16971934)

  • 1. Cancer biology: can less be more for p53?
    Berns A
    Nature; 2006 Sep; 443(7108):153-4. PubMed ID: 16971934
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 and tumor suppression.
    Van Dyke T
    N Engl J Med; 2007 Jan; 356(1):79-81. PubMed ID: 17202460
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour biology: Policing of oncogene activity by p53.
    Efeyan A; Garcia-Cao I; Herranz D; Velasco-Miguel S; Serrano M
    Nature; 2006 Sep; 443(7108):159. PubMed ID: 16971940
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer biology: gone but not forgotten.
    Sharpless NE; DePinho RA
    Nature; 2007 Feb; 445(7128):606-7. PubMed ID: 17251931
    [No Abstract]   [Full Text] [Related]  

  • 5. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.
    Christophorou MA; Ringshausen I; Finch AJ; Swigart LB; Evan GI
    Nature; 2006 Sep; 443(7108):214-7. PubMed ID: 16957739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle control and cancer.
    Sherr CJ
    Harvey Lect; 2000-2001; 96():73-92. PubMed ID: 12200872
    [No Abstract]   [Full Text] [Related]  

  • 7. The INK4a/ARF locus and human cancer.
    Enders GH
    Methods Mol Biol; 2003; 222():197-209. PubMed ID: 12710688
    [No Abstract]   [Full Text] [Related]  

  • 8. The Arf/p53 pathway in cancer and aging.
    Matheu A; Maraver A; Serrano M
    Cancer Res; 2008 Aug; 68(15):6031-4. PubMed ID: 18676821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer: super p53.
    Marte B
    Nature; 2002 Nov; 420(6913):279. PubMed ID: 12447427
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed ageing through damage protection by the Arf/p53 pathway.
    Matheu A; Maraver A; Klatt P; Flores I; Garcia-Cao I; Borras C; Flores JM; Viña J; Blasco MA; Serrano M
    Nature; 2007 Jul; 448(7151):375-9. PubMed ID: 17637672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the tumor suppressor ARF in oncogenesis].
    Pimkina IuS; Dorosevich AE
    Arkh Patol; 2009; 71(1):60-3. PubMed ID: 19514363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARF regulates p19ARF-p53-p21WAF1 senescence pathway by multiple checkpoints.
    Kaul SC; Hasan K; Wadhwa R
    Ann N Y Acad Sci; 2006 May; 1067():217-9. PubMed ID: 16803988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?
    Soussi T; Hjortsberg L
    Trends Mol Med; 2009 Jan; 15(1):1-4. PubMed ID: 19097939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor suppression by cellular senescence: molecular link between aging and cancer].
    Sugimoto M; Takahashi A; Hara E
    Tanpakushitsu Kakusan Koso; 2006 Jan; 51(1):10-7. PubMed ID: 16416878
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer biology: sense out of missense.
    Van Dyke T
    Nature; 2005 Mar; 434(7031):287-8. PubMed ID: 15772635
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of the correlation between genetic and immunohistochemical markers (RB1, p16 and p53 gene regultors of a cell cycle) in sporadic mammary gland carcinoma].
    Nemtsova MV; Zemliakova VV; Kuznetsova EV; Babenko OV; Zavalishina LE; Andreeva IuIu; Bateva MV; Frank GA; Zaletaev DV
    Arkh Patol; 2007; 69(2):3-6. PubMed ID: 17642181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in esophageal cancer.
    Okano J; Snyder L; Rustgi AK
    Methods Mol Biol; 2003; 222():131-45. PubMed ID: 12710684
    [No Abstract]   [Full Text] [Related]  

  • 19. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.